…
Skin Elements Limited engages in the research, development, and commercialization of natural and organic skincare products in Australia. The company offers SuprCuvr, a hospital-grade plant-based disinfectant; ECO Nurture, a plant bio-stimulant; Soléo Organics, a natural and organic sunscreen; PapayaActivs, a natural therapeutics skincare; and Elizabeth Jane Natural Cosmetics, a range of cosmetic skin repair products. It sells its products to wholesale and business customers through distributors, direct sales, its website, and its online store. Skin Elements Limited was founded in 2000 and is based in West Perth, Australia.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Skin Elements Ltd is an Australian company in the skincare and personal-care sector that develops, markets and distributes consumer skin-health products. Long-term growth may be supported by rising skincare demand, product innovation and scaling of direct-to-consumer and wholesale channels, making it a way to access branded personal-care exposure.
Key risks include intense competition in cosmetics and retail, execution risk in scaling brands, regulatory and product-safety exposure, limited liquidity as a small-cap and sensitivity to consumer spending.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
| Income before tax | -5.72M | -1.73M | -3.35M | -4.10M | -1.62M |
| Net income | -5.28M | -1.73M | -2.16M | -4.10M | -1.64M |
| Selling general administrative | - | 1.44M | 0.56M | 1.86M | 1.49M |
| Selling and marketing expenses | - | 0.05M | 0.07M | - | 0.43M |
| Gross profit | 0.20M | 0.41M | 0.36M | 0.10M | 1.04M |
| Reconciled depreciation | - | - | 0.01M | 0.41M | 0.41M |
| Ebit | - | -1.64M | -2.08M | -4.05M | -1.61M |
| Ebitda | -2.35M | -1.63M | -2.08M | -3.64M | -1.20M |
| Depreciation and amortization | - | 0.01M | 0.01M | 0.41M | 0.41M |
| Operating income | -2.35M | -1.63M | -3.02M | -4.05M | -1.61M |
| Other operating expenses | 2.58M | 2.10M | 3.44M | 5.83M | 4.90M |
| Interest expense | 0.06M | 0.09M | 0.08M | 0.06M | 0.01M |
| Tax provision | - | 0.00M | 0.00M | 0.00M | 0.00M |
| Interest income | - | 0.09M | 0.00M | 0.90M | 0.01M |
| Net interest income | - | - | -0.08M | -0.06M | -0.01M |
| Income tax expense | -0.44M | -1.19M | -1.19M | 1.24M | 0.01M |
| Total revenue | 0.23M | 0.47M | 0.42M | 0.19M | 1.41M |
| Total operating expenses | 2.55M | 2.04M | 3.38M | 5.73M | 4.53M |
| Cost of revenue | 0.03M | 0.06M | 0.05M | 0.10M | 0.37M |
| Total other income expense net | -3.36M | -0.09M | -0.33M | 1.18M | -0.01M |
| Net income from continuing ops | - | - | -2.16M | -4.10M | -1.62M |
| Net income applicable to common shares | - | -1.73M | -2.16M | -4.10M | -1.62M |
| Breakdown | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
| Total assets | 1.32M | 0.72M | 0.75M | 9.18M | 11.10M |
| Intangible assets | - | - | - | 7.49M | 7.89M |
| Other current assets | 0.00M | 0.64M | 0.03M | 0.06M | 0.50M |
| Total liab | 0.45M | 2.66M | 1.59M | 1.08M | 1.05M |
| Total stockholder equity | 0.87M | -1.94M | -0.83M | 8.09M | 10.05M |
| Other current liab | 0.09M | 1.80M | - | 0.83M | 0.61M |
| Common stock | 32.65M | 25.87M | 24.44M | 24.24M | 23.04M |
| Capital stock | - | - | - | 24.24M | 23.04M |
| Retained earnings | -33.08M | -28.14M | -26.34M | -17.15M | -13.09M |
| Other liab | - | - | - | - | 0.23M |
| Other assets | - | - | - | - | 0.50M |
| Cash | 0.84M | 0.06M | 0.14M | 0.36M | 0.75M |
| Cash and equivalents | - | - | - | 0.36M | 0.75M |
| Total current liabilities | 0.45M | 2.66M | 1.59M | 1.08M | 0.82M |
| Net debt | -0.54M | 0.38M | -0.13M | -0.34M | -0.72M |
| Short term debt | 0.30M | 0.44M | 0.01M | 0.02M | 0.02M |
| Short long term debt | - | - | - | 0.02M | 0.02M |
| Short long term debt total | 0.30M | 0.44M | 0.01M | 0.02M | 0.02M |
| Other stockholder equity | - | - | - | 0.82M | -0.17M |
| Property plant equipment | - | - | - | 0.01M | 0.02M |
| Total current assets | 1.32M | 0.72M | 0.75M | 1.67M | 2.85M |
| Long term investments | - | - | - | - | 0.50M |
| Net tangible assets | - | - | - | 0.60M | 2.33M |
| Short term investments | - | - | - | 0.00M | 0.50M |
| Net receivables | 0.47M | 0.02M | 0.54M | 1.17M | 1.36M |
| Inventory | - | 0.01M | 0.03M | 0.08M | 0.15M |
| Accounts payable | 0.05M | 0.42M | 1.57M | 0.23M | 0.19M |
| Accumulated other comprehensive income | 1.30M | 0.34M | 1.06M | 1.00M | 0.27M |
| Non currrent assets other | - | - | 0.00M | - | -0.17M |
| Non current assets total | - | 0.00M | 0.01M | 7.50M | 8.25M |
| Long term debt total | - | - | - | 0.00M | 0.00M |
| Breakdown | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
| Investments | - | - | 0.00M | - | - |
| Change to liabilities | - | - | - | 0.09M | 0.19M |
| Total cashflows from investing activities | - | 0.00M | 0.00M | 0.00M | 0.00M |
| Net borrowings | - | - | -0.12M | -0.20M | 0.73M |
| Total cash from financing activities | 3.41M | -0.29M | 0.04M | 1.45M | 1.96M |
| Net income | -5.28M | -1.73M | -2.16M | -4.10M | -1.64M |
| Change in cash | 0.78M | -0.06M | -0.24M | -0.39M | 0.46M |
| Begin period cash flow | 0.06M | 0.12M | 0.36M | 0.75M | 0.29M |
| End period cash flow | 0.84M | 0.06M | 0.12M | 0.36M | 0.75M |
| Total cash from operating activities | -2.63M | 0.23M | -0.28M | -1.84M | -1.23M |
| Issuance of capital stock | - | - | 0.20M | 1.77M | 2.10M |
| Depreciation | - | 0.01M | 0.01M | 0.40M | 0.41M |
| Other cashflows from investing activities | - | 0.00M | 0.00M | 0.00M | 0.00M |
| Change to inventory | - | 0.02M | 0.33M | 0.07M | 0.07M |
| Change to account receivables | - | 0.65M | -0.07M | 0.67M | -0.22M |
| Sale purchase of stock | - | 0.66M | -0.04M | -0.13M | -0.14M |
| Other cashflows from financing activities | - | -0.11M | 0.04M | 0.64M | -0.14M |
| Change to netincome | - | - | - | 8.35M | 0.12M |
| Capital expenditures | 2.63M | 0.00M | 0.00M | 0.00M | 0.00M |
| Change in working capital | - | 0.68M | 0.27M | - | 0.00M |
| Stock based compensation | - | 0.88M | -0.28M | - | - |
| Other non cash items | 2.65M | 0.40M | 1.61M | - | 1.23M |
| Free cash flow | - | 0.23M | -0.28M | -1.84M | -1.23M |
Sector: Consumer Defensive Industry: Household & Personal Products
|
Stock Name
|
Change
(AUD) |
Price
(AUD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| SKN Skin Elements Ltd |
- -% |
0.00 | - | - | 30.26 | 8.04 | 27.95 | -0.22 |
| MCP Mcphersons Ltd |
- -% |
0.13 | - | 16.08 | 0.16 | 0.36 | 0.17 | 16.32 |
| S66 Star Combo Pharma Ltd |
-0.04 20.00% |
0.14 | - | - | 0.80 | 0.61 | 0.42 | 4.45 |
| ZNO ZOONO Group Ltd |
-0.00 5.00% |
0.04 | - | 8.88 | 9.73 | 5.76 | 11.89 | -1.38 |
| AN1 Anagenics Ltd |
0.00 20.00% |
0.01 | - | 4.97 | 0.95 | 1.17 | 1.14 | 7.77 |
Skin Elements Limited engages in the research, development, and commercialization of natural and organic skincare products in Australia. The company offers SuprCuvr, a hospital-grade plant-based disinfectant; ECO Nurture, a plant bio-stimulant; Soléo Organics, a natural and organic sunscreen; PapayaActivs, a natural therapeutics skincare; and Elizabeth Jane Natural Cosmetics, a range of cosmetic skin repair products. It sells its products to wholesale and business customers through distributors, direct sales, its website, and its online store. Skin Elements Limited was founded in 2000 and is based in West Perth, Australia.
| Name | Title | Year Born |
|---|---|---|
| Mr. Peter Francis Malone M.B.A., B.Arch MBA | Exec. Chairman, CEO & MD | NA |
| Mr. Craig Leslie Piercy BBus CA | Chief Financial Officer | NA |
| Mr. Leo Fung | Chief Technical Advisor | NA |
| Mr. Filippo Giglia C.A. | Company Sec. & Independent Non-Exec. Director | NA |
| Mr. Peter Francis Malone M.B.A., B.Arch MBA | Executive Chairman, CEO & MD | NA |
| Mr. Peter Francis Malone M.B.A., B.Arch MBA | Executive Chairman, CEO & MD | NA |
| Mr. Stuart Douglas Usher A.C.I.S., B.Bus., CPA, Grad.Dip. CSP, MBA, MBA B.B | Company Secretary & Independent Non-Executive Director | 1973 |
| Mr. Peter Francis Malone M.B.A., B.Arch MBA | Executive Chairman, CEO & MD | NA |
| Mr. Stuart Douglas Usher A.C.I.S., B.Bus., CPA, Grad.Dip. CSP, MBA, MBA B.B | Company Secretary & Independent Non-Executive Director | 1973 |
| Mr. Peter Francis Malone M.B.A., B.Arch MBA | Executive Chairman, CEO & MD | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.